Financials
- Market Capitalization 23.68 M
- Employee 10
- Founded 2003
- CEO N/A
- Website www.vynetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00H5W8GM8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.94
市销率
43.53
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4550 | NXTC NextCure, Inc. - Common Stock | 6.58 USD | +201.83% | +239.18% | +219.42% | -49.77% | 23.77 M USD | ||
| 4551 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.73 USD | 0.00% | +7.35% | +5.80% | -64.73% | 23.77 M USD | ||
| 4582 | CELU Celularity Inc. - Class A Common Stock | 0.76 USD | 0.00% | 0.00% | -2.56% | -64.49% | 22.00 M USD | ||
| 4586 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.47 USD | -0.88% | +2.75% | -5.80% | +130.26% | 21.81 M USD |